Ajay Tejwani, MD Radiology - Radiation Oncology Medicare: Accepting Medicare Assignments Practice Location: 330 Arkansas St, Suite 120, Lawrence, KS 66044 Phone: 785-749-3600 Fax: 785-749-3621 |
Gregory J Orth, M.D. Radiology - Diagnostic Radiology Medicare: Accepting Medicare Assignments Practice Location: 1700 Lake Alvamar Dr, Lawrence, KS 66047 Phone: 785-760-2937 |
Todd Steven Oberzan, MD Radiology - Diagnostic Radiology Medicare: Accepting Medicare Assignments Practice Location: 1112 W 6th St, Suite 110, Lawrence, KS 66044 Phone: 785-841-3211 |
Darren Klish, M.D. Radiology - Radiation Oncology Medicare: Accepting Medicare Assignments Practice Location: 330 Arkansas St, Suite 120, Lawrence, KS 66044 Phone: 785-749-3600 Fax: 785-749-3621 |
News Archive
The human body has been studied for centuries, but there are still mysteries that are yet to unfold. For instance, it was discovered that there are trillions of bacteria living inside the body, those that are beneficial for health. Now, studies are focused on studying the human microbiome and how they affect health and well-being.
Wu and colleagues studied data for patients under age 65 with at least one diagnosis of Interstitial Cystitis (IC) from a de-identified administrative database of 2 million beneficiaries that included medical, drug and disability claims for 1999-2002.
The 25th of April was observed as World Malaria Day. According to Ray Chambers, the U.N. secretary-general's special envoy for malaria, there has been a marked progress in reducing malaria deaths using bed nets, insecticide spray and drugs. He cited a World Health Organization report in December which used figures from 2010, saying malaria deaths had decreased by over one-third. Since then, he said at a news conference Monday, the world has delivered 160 million additional bed nets "so we expect the number of deaths to be much less now."
Specific combinations of gut bacteria produce substances that affect myelin content and cause social avoidance behaviors in mice, according to a study conducted at the Icahn School of Medicine at Mount Sinai and published today in the medical journal eLife. This research suggests that targeting intestinal bacteria, or their metabolites, could be one way to treat debilitating psychiatric disorders and demyelinating diseases, like multiple sclerosis.
QRxPharmareported today positive outcomes of its European Scientific Advice meetings on the development and registration of MoxDuo IR, an immediate release Dual-Opioid™ pain therapy. The Company is currently completing pivotal Phase 3 trials required for filing a New Drug Application (NDA) for MoxDuo IR with the United States Food and Drug Administration (FDA).
› Verified 7 days ago